Ikonisys Inc. competitors

David Andrew Fischel (born 1 April 1958) is a British businessman. He was formerly the chief executive of Intu Properties Group plc, a British shopping centre management and development company between 2001 and 2019.

Fareed Kureshy is a Chair Of The Board Of Directors / CTO at Therapeutic Holding Inc and is based in Phoenix, Arizona. He has worked as President at Behring Diagnostics, President at PB Diagnostics, and President & CEO at AUTOGENOMICS INC. Fareed attended SMU.

Fortune 500 executive with a dynamic and energizing leadership style. Over 30+ years of consistent and high performing financial and organizational success in the healthcare industry, 20+ years as a senior executive leader. Repeatedly sought after to bring double digit improvements in revenue growth, profitability and market share. Deep expertise in broad business leadership/management, as well as strategic planning and execution. Adept at turning around underperforming businesses with a combination of strong business acumen, outstanding leadership, superior commercial execution, and solid customer relationships. Rapidly adapts to changing market conditions and able to quickly identify and execute on key levers that drive optimal P&L and commercial productivity.Mergers and acquisition experience - including commercial integration and execution of several company acquisitions. During time as President of Given Imaging, Inc - active involvement with key Strategic Initiative for company, which culminated in successful sale of our company to Covidien in Q1, 2014.

Henry Hummel, senior vice president and general manager, Clean Air Division, leads Tenneco's Clean Air product line globally, responsible for continuing Tenneco’s growth in the light vehicle and commercial truck and off-highway markets, and focusing on a range of large engine regulatory-driven opportunities. He is based in Grass Lake, Michigan, and is a member of Tenneco’s senior management team and its executive strategy group. Hummel joined Tenneco in September 2015 from GE Healthcare where, since October 2014, he had been serving as president and CEO of molecular imaging and computed tomography, leading the company’s $3.5 billion global business focused on diagnostic imaging equipment and services. He had been with GE Healthcare for more than 20 years, managing global businesses and functions including operations, strategic planning, new product introductions, technology and business integration. In addition to his time with GE Healthcare, Hummel also spent time with Johnson Controls, Inc., serving as vice president and general manager service North America and Covance, as vice president and general manager of the company’s Madison, Wisconsin laboratories. Hummel holds a bachelor’s degree in computer science from Carroll College in Waukesha, Wisconsin.